Genprex
GNPX • NASDAQ
Genprex is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ryan Confer, with a market cap of $4.4M.
CEORyan Confer
Market Cap$4.4M
Biotechnology
Healthcare
Employees25.0
Websitegenprex.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Genprex
Date
Tuesday, March 31, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Genprex
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$5.00 | — | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.17Est: -$0.71 | +76.1% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.26Est: -$0.42 | +38.1% | - | — | 10-Q |
| Apr 1, 2025 | Q4 2024 | $1.56 | — | - | — | — |
| Nov 13, 2024 | Q3 2024 | -$1.23Est: -$1.93 | +36.3% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$3.00 | — | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$3.69Est: -$5.60 | +34.1% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$3.79Est: -$3.20 | -18.4% | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$5.20Est: -$4.40 | -18.2% | - | — | — |
| Aug 21, 2023 | Q2 2023 | -$6.00 | — | - | — | 10-Q |
| May 22, 2023 | Q1 2023 | -$7.60Est: -$4.80 | -58.3% | - | — | 10-Q |
| Mar 31, 2023 | Q4 2022 | -$6.00Est: -$6.00 | 0.0% | - | — | 10-K |